Skip to content

The Role of Paired-Associated Stimulation in the Discrimination of the Level of Consciousness in Patients with Chronic Disorders of Consciousness

The Role of Paired-Associated Stimulation in the Discrimination of the Level of Consciousness in Patients with Chronic Disorders of Consciousness

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500109193
Enrollment
Unknown
Registered
2025-09-15
Start date
2025-10-09
Completion date
Unknown
Last updated
2025-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prolonged disorders of consciousness

Interventions

unresponsive wakefulness syndrome Group :NA
Minimally Conscious State Group:NA
Healthy Control Group:NA

Sponsors

The First Affiliated Hospital of Air Force Medical University, Chinese People's Liberation Army
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: Inclusion Criteria for Patients: 1. Age 18 to 80 years; 2. State of consciousness disorder due to brain injury or stroke lasting more than 28 days; 3. Stable vital signs, with no acute complications (such as acute pneumonia); 4. Patients or family members voluntarily participate, able to cooperate with the research process and sign the informed consent form. Inclusion Criteria for Healthy Volunteers: 1. Age 18 to 80 years, gender matching chronic consciousness disorder patients; 2. Voluntarily participate, able to cooperate with the research process and sign the informed consent form.

Exclusion criteria

Exclusion criteria: Exclusion criteria for patients: 1.History of epilepsy or family history of epilepsy; 2.Presence of conductive, ferromagnetic, or other magnetically susceptible metals in the head and neck, or presence of a cardiac pacemaker; 3.Severe complications, including heart failure or renal failure; 4.History of alcohol dependence, neurological diseases, and other complex psychiatric disorders; 5.Use of sedative drugs and drugs that may interfere with brain stimulation, such as baclofen or N-methyl-D-aspartate (NMDA) receptor antagonists, within one week before enrollment and during the trial; 6.The patient or their family members refuse to participate in the trial. Exclusion criteria for healthy volunteers: 1.History of epilepsy or family history of epilepsy; 2.Use of sedative drugs and drugs that may interfere with brain stimulation, such as baclofen or N-methyl-D-aspartate (NMDA) receptor antagonists, within one week before enrollment and during the trial; 3.The volunteer refuses to participate in the trial.

Design outcomes

Primary

MeasureTime frame
Cortical Theta Reactivity;TMS-evoked potentials;Event-related spectral perturbation;Local mean field amplitude;Significant current density;Significant oscillation envelope;

Secondary

MeasureTime frame
Significant current scattering;Structural equation model;Coma Recovery Scale Revised Score;

Countries

China

Contacts

Public ContactYuan Hua

The First Affiliated Hospital of Air Force Medical University, Chinese People's Liberation Army

1204923115@qq.com+86 29 8477 5439

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026